Lifecore Biomedical (LFCR) Tops Q2 EPS by 2c

Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $32.56 million versus the consensus estimate of $30.18 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Prologis makes unsolicited bid for SEGRO, valued at £12.6 billion